Evidence map›Paper›PMID 42591264›Full record

ArticleFrontiers in network physiology2026

Multi-omic enriched blood-derived digital signatures reveal mechanistic and confounding disease clusters for differential diagnosis.

Bolin Liu, Abicumaran Uthamacumaran, Alexander Fulton, Hector Zenil

Abstract read
In one paragraph

Article in Frontiers in network physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bolin LiuAlgorithmic Dynamics Lab, King's Institute for Artificial Intelligence, King's College London, London, United Kingdom.
Abicumaran UthamacumaranOxford Immune Algorithmics, Oxford University Innovation and London Institute for Healthcare Engineering, London, United Kingdom.
Alexander FultonOxford Immune Algorithmics, Oxford University Innovation and London Institute for Healthcare Engineering, London, United Kingdom.
Hector ZenilAlgorithmic Dynamics Lab, King's Institute for Artificial Intelligence, King's College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Understanding disease relationships through blood biomarkers offers a pathway toward data-driven taxonomy and precision medicine. Methods: In this study, we constructed a digital blood twin --a computational model derived from 103 disease signatures comprising longitudinal hematological and biochemical analytes. Profiles were standardized into a unified disease -analyte matrix, and pairwise Pearson correlations were computed to assess similarity across conditions. Results: Hierarchical clustering within a phylogenetic framework revealed consistent, robust grouping of hematopoietic disorders, while metabolic, endocrine, and respiratory diseases were more heterogeneous, reflecting weaker internal cohesion. To evaluate cluster structure, the tree was partitioned at a stringent distance threshold, yielding 16 groups. Enrichment analysis of the largest and most heterogeneous cluster (Cluster 9) demonstrated convergence on cytokine-signaling pathways, indicating shared immunological and inflammatory mechanisms that transcend conventional clinical boundaries. Dimensionality reduction using Principal Component Analysis (PCA) and Uniform Manifold Approximation and Projection (UMAP) corroborated the correlation-based results, consistently separating hematological diseases as a distinct cluster. Random Forest feature selection identified neutrophils, mean corpuscular volume (MCV), red blood cell count, and platelet count as the most discriminative analytes, reinforcing the role of hematopoietic markers as key drivers of disease stratification. Discussion: Collectively, these findings demonstrate that blood-derived digital signatures can recover clinically meaningful disease clusters while uncovering mechanistic overlaps across categories. The strong coherence of hematological diseases contrasts with the dispersion of systemic and metabolic disorders, underscoring both the promise and limits of blood-based approaches for disease classification. This network physiology framework highlights the potential of integrating routine laboratory data with computational methods to refine disease ontology, map comorbidities, and advance precision diagnostics.

Indexed as

blood-derived biomarkersdisease signatureshematologynetwork physiologysystems medicine

Identifiers

PMID42591264
PMCPMC13461528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.